Influence of ESG Performance on Stock Repurchase Decision of the Pharmaceutical and Biological Industry
Main Article Content
Keywords
ESG performance, stock repurchase, consumer confidence index
Abstract
The practice of ESG in the pharmaceutical and biological industry is directly related to public health and social trust. The correlation mechanism between ESG performance and capital operation behavior has a stronger research necessity and practical significance than other industries. This paper takes China’s A-share listed companies in the pharmaceutical and biological industry from 2015 to 2024 as the research object to explore the impact of ESG on stock repurchases. The study found that the better the ESG comprehensive performance of Listed Companies in the pharmaceutical and biological industry, the more obvious their stock repurchase tendency, and the results were still robust after passing the endogenous test. The mechanism test found that the consumer confidence index was the intermediary variable, and ESG could promote stock repurchase by improving consumer confidence. Further heterogeneity analysis shows that ESG has a significant positive impact on stock repurchase in non-state-owned enterprises, while the impact is not obvious in state-owned enterprises.
References
- [1] Yang, R. B., Tao, D. C. and Hou, X. Z. Research on the impact of ESG performance on corporate financial performance. Technical Economics. 2023, 42(8), pp. 124-134.
- [2] Huang, H. and Xiao, C. s. Timing ability and influencing factors of stock repurchase of listed companies. Research on Financial Issues. 2016(2), pp. 33-39. https://doi.org/10.19654/j.cnki.cjwtyj.2016.02.005.
- [3] Gan, S. D. and Lin, M. On the path of stock repurchase affecting enterprise value. Financial Science. 2010(1), pp. 71-75.
- [4] Jiang, Y. R. and Wu, F. A study on the impact of public environmental concerns on the ESG performance of pharmaceutical companies. Communication of Finance and Accounting. 2025(21), pp. 54-58. https://doi.org/10.16144/j.cnki.issn1002-8072.2025.21.005.
- [5] Wang, K. The impact of implementing ESG on the financial performance of pharmaceutical manufacturing enterprises: Taking Company B as an example. China Market. 2025(28), pp. 127-130. https://doi.org/10.13939/j.cnki.zgsc.2025.28.031.
- [6] Ma, J. F. Research on the Impact of Enterprise ESG Performance on Stock Repurchase. Master’s Thesis, Ganzhou: Jiangxi University of Science and Technology, 2024. https://doi.org/10.27176/d.cnki.gnfyc.2024.001092.
- [7] Zhang, H. P. and Cao, C. Y. The Impact of Tail Risk on Capital Market Effects: Mediating Role of Investor Sentiment and Belief. Journal of Management. 2025, 38(5), pp. 84-102. https://doi.org/10.19808/j.cnki.41-1408/f.2025.0050.
- [8] Li, Y. Research on the impact of consumer confidence index on risk contagion in the stock market. Master’s Thesis, Changsha: Hunan University, 2018.
- [9] Gao, Z. B. and Liang, X. B. Research on the impact of investor sentiment on stock market returns based on VAR and EGARCH. Journal of Zhejiang University(Science Edition). 2023, 50(4), pp. 434-441,454.
- [10] Jin, G. Research on the Influence Mechanism of Stock Repurchase on Corporate Green Innovation: A Study of Listed New Energy Enterprises. Master’s Thesis, Nanchang: Jiangxi Normal University, 2024.
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.